Glucagon-like peptide-1 (GLP-1) and the control of glucose metabolism in mammals and teleost fish

American Zoologist

Volumn 40, Issue 2, 2000, Pages 246-258

  Mojsov, Svetlana ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 23044518919     PISSN: 00031569     EISSN: None     Source Type: Journal    
DOI: 10.1093/icb/40.2.246     Document Type: Article

References (71)

1. Andrews, P. C. and P. Ronner. 1985. Isolation and structures of glucagon and glucagon-like peptide from catfish pancreas. J. Biol. Chem. 260:39103914.
2. Bell, G. T., R. E Saniere, and G. T. Mullenbach. 1983. Hamster preproglucagon contains the sequences of glucagon and two related peptides. Nature 302: 716-719.
3. Blackmore, P. F., S. Mojsov, J. H. Exton, and J. R Habener. 1991. Absence of insulinotropic glucagon-like peptide-I (7-37) receptors on isolated rat liver hepatocytes. FEES Lett. (1991) 283:7-10.
4. Bromer, W. W. 1983. Chemical characterization of glucagon. In P. J. Lefebre (ed.), Handbook of experimental pharmacology, Vol. 66/1. Spritiger-Verlag, Berlin, Heidelberg, New York, Tokyo;
5. Bullock, B. P., S. R. Heller, and J. F. Habener. 1996. Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor. Endocrinology 137:2968-2978.
6. Chen, Y. E. and D. J. Drucker. 1997. Tissue-specific expression of unique mRNAs that encode proglucagon-derived peptides or exendin-4 in the lizard. J. Biol. Chem. 272:4108-4115.
7. Conlon, M. J., S. Falkmer, and L. Thim. 1987. Primary structurés of three fragments of proglucagon from the pancreatic islets of daddy sculpin (Coitus scorpius). Eur. J. Biochem. 164:117-122.
8. Creutzfeldt, W. 1979. The incretin concept today. Diabetologia 16:75-85.
9. Creutzfeldt, W. and R. Ebert. 1985. New developments in the incretin concept. Diabetologia 28:565-573.
10. Creutzfeldt, W., C. Orskov, N. Kleine, J. J. Holst, B. Willms, and M. A. Nauck. 1996. Glucagonostatic actions and reduction of fasting hyperglycemia by exogenous glucagon-like peptide 1(7-36) amide in Type 1 patients. Diabetes Care 19:580-586.
11. Dijk, van G., T. E. Thiele, R. J. Seeley, S. C. Woods, and I. L. Bernstein. 1997. Glucagon-like peptide1 and satiety. Nature 385:214.
12. Dunphy, J. L., R. G. Taylor, and P. J. Fuller. 1998. Tissue distribution of rat glucagon receptor and GLP-1 receptor gene expression. Mol. Cell. Endocrinol. 141:179-186.
13. Eng, J., W. A. Klenman, L. Singh, G. Singh, and J-P. Raufman. 1992. Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. J. Biol. Chem. 267:74027405.
14. Eng, J. and C. Eng. 1992. Exendin-3 and exendin-4 are insulin secretagogues. Regul. Pept. 40:142145.
15. Furnsinn, C., K. Ebner, and W. Waldhausl. 1995. Failure of GLP-1 (7-36) amide to affect glycogenesis in rat skeletal muscle. Diabetologia 38:864-867.
16. Gefel, D., G. K. Hendrick, S. Mojsov, J. F. Habener, and G. C. Weir. 1990. Glucagon-like peptide-1 analogs: Effects on insulin secretion and adenosine 3', 5'-monophosphate formation. Endocrinology, 126:2164-2168.
17. Goke, R. and M. C. Conlon. 1988. Receptors for glucagon-like peptide-1 (7-36) amide on rat insulinoma derived cells. J. Endocrinol. 116:357-362.
18. Goke, R., H. C. Fehmann, T. Linn, H. Schmidt, M. Krause, J. Eng, and B. Goke. 1993. Exendin-4 is a high potency agonist and truncated exendin- (939)-amide is an antagonist at the glucagon-like peptide-1 (7-36) amide receptor on insulin secreting -cells. J. Biol. Chem. 268:19650-19655.
19. Gutniak, M., C. Orskov, J. J. Holst, B. Ähren, and S. Efendic. 1992. Antidiabetogenic effect of glucagon-like peptide-I (7-36) amide in normal subjects and patients with diabetes mellitus. N. Engl. J. Med. 326:13.16-1322.
20. Hansen, B. F., P. Jensen, E. Nepper-Christensen, and B. Skjolstrup. 1998. Effects of glucagon-like peptide-1 (7-36) amide on insulin stimulated rat skeletal muscle glucose transport. Acta Diabetol. 35: 101-103.
21. Hargrove, D. M., N. A. Nardone, L. M. Persson, K. M. Andrews, K. L. Shepherd, R. W. Stevenson, and J. C. Parker. 1996. Comparison of glucose dependency of glucagon-like peptide-1 (7-37) and glyburide in vitro and in vivo. Metabolism, Clinical and Experimental. 45:404-409.
22. Heinrich, G., P. Gros, P. K. Lund, R. C. Bentley, and J. F. Habener. 1984. Pre-proglucagon messenger ribonucleic acid: Nucleotide and encoded amino acid sequences of the rat pancreatic complementary deoxyribonucleic acid. Endocrinology 115: 2176-2181.
23. Hoist, J. J., C. Orskov, O. V. Nielsen, and T. W. Schwanz. 1987. Truncated glucagon-like peptide-1. an insulin-releasing hormone from the distal gut. FEES Lett. 211:169-174.
24. Irwin, D. M. and J. Wong. 1995. Trout and chicken proglucagon: Alternative splicing generates mRNA transcripts encoding glucagon-like peptide 2. Mol. Endocrinol. 9:267-277.
25. Irwin, D. M., M. Satkunarajah, Y. Wen, P. L. Brubaker, R. Pederson, and M. B. Wheeler. 1997. The Xenopus proglucagon gene encodes novel GLP-1 like peptides with insulinotropic properties. Proc. Natl. Acad. Sei. U.S.A. 94:7915-7920.
26. Kolligs, F., H-C. Fehmann, R. Goke, and B. Goke. 1995. Reduction of the incretin effect in rats by the glucagon-like peptide-1 receptor antagonist exendin (9-39). Diabetes 44:16-19.
27. Kreymann, B., M. A. Ghatei, G. Williams, and S. R. Bloom. 1987. Glucagon-like peptide-I 7-36: A physiological incretin in man. Lancet 2:13001303.
28. Lankat-Buttgereit, B., R. Goke, H. C. Fehmann, G. Richter, and B. Goke. 1994. Molecular cloning of a cDNA encoding the GLP-1 receptors expressed in rat lung. Exp. Clin. Endocrinol. 102:341-347.
29. Lopez, L. C., M. L. Frazier, C. J. Su, A. Kumar, and G. F. Saunders. 1983. Mammalian pancreatic preproglucagon contains three glucagon-related peptides. Proc. Natl. Acad. Sei. U.S.A. 80:54855489.
30. Lund, P. K., R. H. Goodman, M. R. Montimony, P. Dee, and J. F. Habener. 1982. Pancreatic preproglucagon cDNA contains two glucagon-related coding sequences arranged in tandem. Proc. Natl. Acad. Sei. U.S.A. 79:345-349.
31. Lund, P. K., R. H. Goodman, M. R. Montimony, P. Dee, and J. F. Habener. 1983. Anglerfish islet preproglucagon. II. Nucleotide and corresponding amino acid sequence of cDNA. J. Biol. Chem. 258:3280-3284.
32. Mark, C., B. Edwards, J. F. Todd, M. Mahmoudi, Z. Wang, R. M. Wang, M. A. Ghatei, and S. R. Bloom. 1999. Glucagon-like peptide 1 has a phys-iological role in the control of postprandial glucose in humans: Studies with the antagonist exendin 9-39. Diabetes 48:86-93.
33. Mojsov, S., G. C. Weir, and J. F. Habener. 1987. Insulinotropin: Glucagon-like peptide I (7-37) coencoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas. J. Clin. Invest. 79:616-619.
34. Mojsov, S. 1992. Structural requirements for biological activity of glucagon-like peptide-I. Int. ,'j. Pept. Prot. Res. 40:333-343. ,'
35. Mommsen, T. P., P. C. Andrews, and E. Plisetskaya. 1987. Glucagon-like peptides activate hepatic gluconeogenesis. FEES Lett. 219:227-232.
36. Mommsen, T. P. and T. W. Moon. 1989. Metabolic actions of glucagon-family hormones in liver. Fish Physiol. Biochem. 7:279-288.
37. Mommsen, T. P. and T. W. Moon. 1990. Metabolic response of teleost hepatocytes to glucagon-like peptide and glucagon. J. Endocrinology 126:109118. "
38. Mommsen, T. P. and E. M. Plisetskaya. 1991. Insulin in fishes and agnathans: History, structure and metabolic regulations. Rev. Aquat. Sei. 4:225259.
39. Mommsen, T. P. and S. Mojsov. 1998. Glucagon-like peptide activates the adenylyl cyclase system in rockfish enterocytes and brain membranes. Comp. Biochem. Physiol. 1998; 121B:49-56.
40. Morales, M., M. I. Lopez-Delgado, A. Alcantara, M. A. Luque, F. Clémente, L. Marquez, J. Puente, C. Vinambres, W. J. Malaisse, M. L. Villanueva-Penacarrillo, and I. Valverde. 1997. Preserved GLP-1 effects on glycogen synthase a activity and glucose metabolism in isolated hepatocytes and skeletal muscle from diabetic rats. Diabetes 46:12641269.
41. Nathan, D. M., E. Schreiber, H. Fogel, S. Mojsov, and J. E Habener. 1992 Insulinotropic action of glucagon-like peptide-I (7-37) in diabetic and nondiabetic subjects. Diabetes Care 15:270-276.
42. Nauck, M. A., M. M. Heimesaat, C. Orskov, J. J. Holst, R. Ebert, W. Creutzfeldt. 1993. Preserved incretin activity of glucagon-like peptide-1 [7-36 Amide] but not synthetic gastric inhibitory polypeptide in patients with TVpe-2 Diabetes Mellitus. J. Clin. Invest. 91:301-317.
43. Nauck, M. A., U. Niedereichholz, R. Eitler, J. J. Holst, C. Orskov, R. Ritzel, and W. H. Schmiegel. 1997. Glucagon-like peptide-1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans. Am. J. Physiol. 273:E981-E988.
44. Nguyen, T. M., J. R. Wright, Jr., P. F. Nielsen, and J. M. Conlon. 1995. Characterization of the pancreatic hormones from the Brockman body of tilapia: Implications for islet xenograft studies. Comp. Biochem. Physiol. 111:33-44.
45. Okamoto, T., Y. Murayama, Y. Hayashi, M. Inagaki, E. Ogata, and I. Nishimoto. 1991. Identification of Gs activator region of the beta-2 adrenergic receptor that is autoregulated via protein kinase Adependent phosphorylation. Cell 67:723-730.
46. Orskov, C., J. J. Hoist, and O. V. Nielsen. 1988. Effect of truncated glucagon-like peptide-1 [progluca-gon- (78-107) amide] on endocrine secretion from pig pancreas, antrum, and nonantrial stomach. Endocrinology 123:2009-2013.
47. Orskov, C., A. Wettergren, and J. J. Hoist. 1993. Biological effects arid metabolic rates of glucagonlike peptide-1 7-36 amide and glucagon-like peptide-1 7-37 in healthy subjects are indistinguishable. Diabetes 42:658-661.
48. Parker, J. C., K. M. Andrews, D. M. Rescek, W. Massefski, Jr., G. C. Andrewes, L. G. Contillo, R. W. Stevenson, D. H. Sinleton, and R. T. Suleske. 1998. Structure-function analysis of a series of ^glucagon-like peptide-1 analogs. J. Pept. Res. 52: 398-409.
49. Plisetskaya, E. M., H. G. Pollock, J. B. Rouse, J. W. Hamilton, J. R. Kimmel, and A. Gorbman. 1986. Isolation and structures of coho salmon (Oncorhynchus kisutch) glucagon and glucagon-like peptide. Regul. Pept. 14: 57-67.
50. Plisetskaya, E. M. and T. P. Mommsen. 1996. Glucagon and glucagon-like peptides in fishes. Int. Rev. Cytol. 168:187-257.
51. Pohl, M. and S. A. Wank. 1998. Molecular cloning of the helodermin and exendin-4 cDNAs in the lizard. J. Biol. Chem. 273:9778-9784.
52. Schirm, J., K. Sturm, P. Leicht, R. Arnold, B. Goke, and M. Katshinsky. 1998. Exendin (9-39) amide is an antagonist of glucagon-like peptide-1 (7-36) amide in humans. J. Clin. Invest. 101:1421-1430.
53. Segre, G. V. and S. R. Goldring. 1993. Receptors for secretin, calcitonin, parathyroid hormone (PTH)/ PTH-related peptide, vasoactive intestinal peptide, glucagon-like peptide-1, growth hormone-releasing hormone and glucagon belong to a newly discovered G-protein linked receptor family. Trend. Endocrinol. Metab. 4:309-314.
54. Thiele, T. E., G. van Dijk, L. A. Campfield, F. J. Smith, P. Burn, S. C. Woods, H. Bernstein, and R. J. Seely. 1997. Central infusion of GLP-1, but not leptin, produces conditioned taste aversion in rats. Am. J. Physiol. 272:R848-R856.
55. Thorens, B. 1992. Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1. Proc. Natl. Acad. Sei. U.S.A. 89:8641-8645.
56. Thorens, B., A. Porret, L. Buhler, S. P. Deng, P. Morel, and C. Widmann. 1993. Cloning and functional expression of the human islet GLP-1 receptor. Demonstration that exendin-4 is an agonist and exendin- (9-39) an antagonist of the receptor. Diabetes 42:1678-1682.
57. Tolessa, T., M. Gutniak, J. J. Hoist, S. Efendic, and P. M. Hellstrom. 1998. Inhibitory effect of glucagonlike peptide-1 on small bowel motility. J. Clin. Invest. 102:764-774.
58. Turton, M. D., D. O'Shea, I. Gunn, S. A. Beak, C. M. B. Edwards, K. Meeran, S. J. Choi, G. M. Taylor, M. M. Heath, P. D. Lambert, J. P. H. Wilding, D. M. Smith, M. A. Ghatei, J. Herbert, and S. R. Bloom. 1996. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 379: 69-72.
59. Unger, R. H. and A. M. Eisentraut. 1969. Enteroinsular axis. Arch. Intern. Med. 123:261-266.
60. Valverde, I., E. Merida, E. Delgado, M. A. Trapotes, and M. I. Villanueva-Penacarillo. 1993. Presence and characterization of glucagon-like peptide-1 (7-36) amide receptors in solubilized membranes of rat adipose tissue. Endocrinology 132:75-79.
61. Valverde, I., M. Morales, E Clémente, M. I. LopezDelgado, E. Delgado, A. Perea, and M. L. Villanueva-Penacarillo. 1994. Glucagon-like peptide I: A potent glycogenic hormone. FEES Lett. 349: 313-316. J
62. Villanueva-Penacarillo, M. I., A. L. Alcantara, F. Clé mente, E. Delgado, and I. Valverde. 1994. Potent glycogenic effect of GLP-1 (7-36) amide in rat skeletal muscle. Diabetologia 1163-1166.
63. Wang, Z., R. M. Wang, A. A. Owji, D. M. Smith, M. A. Ghatei, and S. R. Bloom. 1995. Glucagon-like peptide-1 is a physiological incretin in rat. J. Clin. Invest. 95:417-421.
64. Wei.Y. and S. Mojsov. 1995. Tissue-specific expression of the human receptor for glucagon-like peptide-I: Brain, heart and pancreatic forms have the same deduced amino acid sequences. FEES. Lett. 358:219-224.
65. Wei, V. and S. Mojsov. 1996. Tissue specific expression of different human receptor types for pituitary adenylate cyclase activating polypeptide and vasoactive intestinal polypeptide: Implications for their role in human physiology. J. Neuroendocrinology 8:811-817.
66. Weir, G. C., S. Mojsov, G. K. Hendrick, and J. F. Habener. 1989. Glucagon-like peptide I (7-37) actions on the endocrine pancreas. Diabetes 38:338342.
67. Wettergen, A., B.-i Schjoldager, P. E. Mortensen, J. Myhre, J. Chrisiansen, and J. J. Hoist. 1993. Truncated GLP-1 (proglucagon 78-107 amide) inhibits gastric and pancreatic functions in man. Dig. Dis. Sei. 38:665-673.
68. Willms, B., J. Werner, J. J. Hoist, C. Orskov, W. Creutzfeldt, and M. A. Nauck. 1996. Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: Effects of exogenous glucagon-like peptide-1 (GLP-l)-(7-36) amide in Type 2 (noninsulin-dependent) diabetic patients. J. Clin. Endo. Metab. 81:327-332.
69. Wright, J. R., Jr., W. O'Hali, W.Yang, X. X. Han, and A. Bonen. 1998. GLUT-4 deficiency and severe peripheral resistance to insulin in the teleost fish tilapia. Gen. Comp. Endocrionol. 111:20-27.
70. Yuen, T. T. H., P. Y. Mok, and B. K. C. Chow. 1997. Molecular cloning of a cDNA encoding proglu-\., cagon from goldfish, Carassius auratus. Fish. Phys. Biochem. 17:223-230.
71. Zunz, E. and J. La Barre. 1929. Contributions a l'étude des variations physiologiques de la secretion interne due pancreas: Relations entre les secretions externe et interne du pancreas. Arch. Intern. Physiol. Biochim. 31:20-24.